• Focus on Melanoma Virtual Meeting 15th October 2021

Focus on Melanoma Virtual Meeting 15th October 2021

We are delighted to announce that registration is now open for this year’s Focus on Melanoma Virtual Meeting. The event is organised by Dr. Andrew Furness, The Royal Marsden Hospital

This meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credits.
The Royal College of Surgeons of England has awarded up to 6 CPD points for this event and the British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 8 CME credits.

Please submit your poster abstracts by 19 September 2021 (250 words maximum) to Michelle at mbridge@melanomafocus.org

If you are unsure about your membership, please contact Michelle at mbridge@melanomafocus.org.

2021 Registration Fees:

Member
Consultant £149
Other Clinician / Student £119
Nurse / AHP £49
Non-Member
Consultant £199
Other Clinician / Student £154
Nurse / AHP £79
Industry £249

2021 Draft Programme:

09:00 – 09:15 Welcome/Introductions (Mark Harries / Imogen Cheese)
09:15 – 10:00 The Martin Gore Memorial Prize Lecture
Towards zero deaths from melanoma
Professor Georgina Long – Co-Medical Director/Chair of Melanoma Medical Oncology & Translational Research, Melanoma Institute of Australia/Royal North Shore Hospital, The University of Sydney
09:15 – 12:15 Pharma Exhibition Area
10:10 – 10:50 Virtual Networking x 4 concurrent (Surgeons/Dermatologists/Oncologists/CNS)

CNSs – ‘Skin Cancer CNS census 2021 – initial feedback, discussion and next steps’ – facilitated by Jackie Hodgetts
Dermatologists – ‘Teledermatology – for better or for worse’ – facilitated by Dr Julia Schofield
Oncologists – ‘Adjuvant treatment in stage 2 melanoma’ – Facilitated by Dr Ruth Board & Dr Becki Lee
Surgeons – ‘Training the next generation of skin cancer surgeons’ – facilitated by Mr Siva Kumar

11:00 – 12:00 Bristol Myers Squibb Sponsored Symposium:
Advancing treatments in patients with BRAF-mutated advanced melanoma
Dr Toby Talbot, Consultant Medical Oncologist, Royal Cornwall Hospitals NHS Trust
12:30 – 12:35 Welcome
Dr Andrew Furness – Consultant Medical Oncologist/Team Leader, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
12:35 – 13:40 Session 1: COVID-19 and Cancer
Chair: Dr Samra Turajlic – Group Leader/Consultant Medical Oncologist, The Francis Crick Institute & Royal Marsden NHS Foundation Trust
12:35 – 13:00 The CAPTURE study – biological insights and implications for cancer patients
Dr Scott Shepherd, CRUK Clinical Research Fellow,  The Francis Crick Institute & Royal Marsden NHS Foundation Trust
13:00 – 13:25
The impact of COVID-19 on well-being in the oncology workforce – results from the ESMO Resilience Task Force and COVID-NOW survey series
Dr Jonathan Lim, Clinical Research Fellow – Imperial College London, The Francis Crick Institute and The Christie NHS Foundation Trust.
13:25 – 13:40 Q & A
13:40 – 14:45 Session 2: Novel loco-regional approaches
Dr Anna Olsson-Brown, MRC Clinical Research Fellow, Clatterbridge Cancer Centre
13:40 – 14:05 Modulation of local and systemic anti-cancer immunity via injectable therapies
Professor Kevin Harrington – Group Leader/Consultant Clinical Oncologist, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust
14:05 – 14:30 The TITAN study – from bench to bedside: a surgical loco-regional interventional study
Mr Andrew Hayes – Consultant Surgical Oncologist/Team Leader, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
14:30 – 14:45 Q&A
   
14:45 – 14:55 Comfort Break
14:55 – 16:25 Session 3: Breakthrough systemic therapies
Chair: Dr Paul Nathan, Consultant Medical Oncologist, Mount Vernon Cancer Centre
14:55 – 15:20 Tebentafusp – a bi-specific TCR therapeutic for uveal melanoma
Dr Joe Sacco – Consultant Medical Oncologist/Clinical Senior Lecturer, The Clatterbridge Cancer Centre/University of Liverpool
15:20 – 15:45 Lifileucel – a tumour-infiltrating lymphocyte therapy for advanced melanoma
Dr Andrew Furness – Consultant Medical Oncologist/Solid Tumour Cellular Therapy Lead, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
15:45 – 16:10
Modulation of the gut microbiome for therapeutic gain
Dr Jennifer McQuade – Consultant Medical Oncologist/Physician-Scientist, MD Anderson Cancer Centre
16:10 – 16:25 Q&A
   
 16:25 – 17:20 Session 4: MDT – management of ano-uro-genital mucosal melanoma (case-based discussions)
Chair: Mr Myles Smith, Consultant Surgical Oncologist and General Surgeon, The Royal Marsden NHS Foundation Trust/Institute of Cancer Research
Panel:
Mr Asif Muneer, Consultant Urological Surgeon, University College London Hospitals
Mr Desmond Barton, Consultant Gynaecologist Oncologist, Royal Marsden Hospital
Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital
17:20 – 17:30 Concluding Remarks and Close
Dr Mark Harries, Chairman Melanoma Focus, Dr Andrew Furness, Organiser
Imogen Cheese, Melanoma Patient Conference

printer-friendly version